ABSTRACT Respiratory Syncytial Virus (RSV) causes lower respiratory tract infections that
can be severe and sometimes fatal. The risk for severe RSV infection is highest in infants …

Background Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality
among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized …

Background Respiratory syncytial virus (RSV) infection causes considerable illness in older
adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein–based …

Background The aim of this study was to investigate safety and immunogenicity of vaccine
formulations against respiratory syncytial virus (RSV) containing the stabilized prefusion …

Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory
infection, lower respiratory tract disease, clinical complications, and death in older adults …

Background Respiratory syncytial virus (RSV) is an important cause of illness in older adults.
This study assessed efficacy of a vaccine for prevention of RSV-associated acute respiratory …

Background Although human respiratory syncytial virus (RSV) is an important cause of
illness and death in older adults, no RSV vaccine has been licensed. Methods In a phase 2a …

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection (LRTI)
annually affecting> 2 million children in the United States< 5 years old. In the elderly (> 65 …

Background A preventative strategy for Respiratory Syncytial Virus (RSV) infection
constitutes an under-recognized unmet medical need among older adults. Four formulations …

Background Older adults with chronic cardiorespiratory or endocrine/metabolic conditions
are at increased risk of respiratory syncytial virus (RSV)-related acute respiratory illness …